Movers and Shakers: Business personnel announcements

Daniel B. DiFrancesco has been named global equity research associate in the investments team at Turner Investments, an employee-owned investment firm based in Berwyn.

In this position, DiFrancesco, 23, supports Turner’s consumer team, one of five teams of security analysts that cover the nine market sectors and make investment recommendations for the firm’s growth-stock portfolios. He assists Turner’s five consumer analysts with their fundamental research of global growth stocks by compiling and analyzing investment information, developing computer models and participating in meetings with company managements and Wall Street strategists and analysts.

DiFrancesco previously served as an equity research co-op employee at Turner, which was founded in 1990 and manages growth, global/international, and long/short portfolios in stocks for both institutions and individuals. Turner manages more than $10 billion in assets, as of March 31, 2013.

Advertisement

Dr. Andrew Murphy of Asthma, Allergy and Sinus Center has been elected to serve on the board of directors of the American Academy of Allergy, Asthma and Immunology, or AAAAI. The AAAAI is a professional group of allergist/immunologists, medical specialists and health care professionals who are specialty trained in the research and treatment of allergic and immunologic diseases. The AAAAI has more than 6,500 members around the world.

In addition, Murphy was elected vice chairman of the Federation of Regional, State and Local Allergy, Asthma and Immunology Societies, which is an assembly of the AAAAI that promotes and supports allergists and quality patient care at the grassroots level.

He has offices in West Chester, Coatesville and Kennett Square.

Paul Perreault has assumed the role of CEO and managing director of CSL Limited, a global specialty biotherapeutics company. Perreault replaces Brian McNamee, who is retiring after leading the company for 23 years.

Perreault joined CSL in 2004 as part of the Aventis Behring acquisition. He most recently served as the president of CSL’s core business, and largest wholly owned subsidiary, CSL Behring. Headquartered in King of Prussia, the company employs approximately 450 people in the Philadelphia area and more than 10,000 people globally.

Vanguard has reassigned portfolio management responsibilities for five funds, effective June 28, as follows: James D’Arcy has assumed responsibility for the $38.6 billion Vanguard Intermediate-Term Tax-Exempt Fund and the municipal bond portion of Vanguard Tax-Managed Balanced Fund. Mathew M. Kiselak and Adam M. Ferguson have been named co-managers of the $3.4 billion Vanguard New York Long-Term Tax-Exempt Fund. Kiselak has also assumed responsibility for the $2.1 billion Vanguard New Jersey Long-Term Tax-Exempt Fund. The four funds were managed by Michael Kobs, who has left the firm.

In addition, Ferguson has been named co-manager of the $7.2 billion Vanguard California Intermediate-Term Tax-Exempt Fund. James D’Arcy had been the sole manager of the fund.